ConductScience.org, home

Paper15857504

In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line.

Hoffmeyer MR and 2 others. Cancer Cell Int, 2005. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line. Papers, record 15857504. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15857504

Download JSON
Cell line
SUM149PT75 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line.
PubMed
Journal
Cancer Cell Int
PubMed
Year
2005
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
0.86
iCite
Revised in PubMed
2020-09-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hoffmeyer MRMichaela R
2Wall KMKristin M
3Dharmawardhane SFSuranganie F

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R21CA083957NIH

Source NIH RePORTER

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110887484Human breast cancer cell lines as models of growth regulation and disease progression.J Mammary Gland Biol Neoplasia1996https://conductscience.org/library/papers/10887484PubMed
210537277A novel human xenograft model of inflammatory breast cancer.Cancer Res1999https://conductscience.org/library/papers/10537277PubMed
311353057Persistent E-cadherin expression in inflammatory breast cancer.Mod Pathol2001https://conductscience.org/library/papers/11353057PubMed
49472046CAS/Crk coupling serves as a "molecular switch" for induction of cell migration.J Cell Biol1998https://conductscience.org/library/papers/9472046PubMed
510952316Genomic analysis of metastasis reveals an essential role for RhoC.Nature2000https://conductscience.org/library/papers/10952316PubMed
612808121Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.Lab Invest2003https://conductscience.org/library/papers/12808121PubMed
711082269Rho GTPases: signaling, migration, and invasion.Exp Cell Res2000https://conductscience.org/library/papers/11082269PubMed
88610272Inflammatory breast cancer.Surg Clin North Am1996https://conductscience.org/library/papers/8610272PubMed
912530938The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.Curr Hypertens Rep2003https://conductscience.org/library/papers/12530938PubMed
1011809710Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft.Cancer Res2002https://conductscience.org/library/papers/11809710PubMed
1110375527Interplay between Rac and Rho in the control of substrate contact dynamics.Curr Biol1999https://conductscience.org/library/papers/10375527PubMed
1212032865Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma.Oncogene2002https://conductscience.org/library/papers/12032865PubMed
1310648558RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism.J Cell Biol2000https://conductscience.org/library/papers/10648558PubMed
149930872An essential part for Rho-associated kinase in the transcellular invasion of tumor cells.Nat Med1999https://conductscience.org/library/papers/9930872PubMed
159459160Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.Br J Cancer1998https://conductscience.org/library/papers/9459160PubMed
1611128990Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton.Philos Trans R Soc Lond B Biol Sci2000https://conductscience.org/library/papers/11128990PubMed
1712618881Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression.Br J Cancer2003https://conductscience.org/library/papers/12618881PubMed
1812718869Closing the GAP: a role for a RhoA GAP in cytokinesis.Mol Cell2003https://conductscience.org/library/papers/12718869PubMed
193856043Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program.J Natl Cancer Inst1985https://conductscience.org/library/papers/3856043PubMed
2012361600Actin cable dynamics and Rho/Rock orchestrate a polarized cytoskeletal architecture in the early steps of assembling a stratified epithelium.Dev Cell2002https://conductscience.org/library/papers/12361600PubMed

See all 41 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42748134From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells.PLoS One2026https://conductscience.org/library/papers/42748134PubMed
40366255E-Cadherin Is a Structuring Component of Invadopodia in Pancreatic Cancer.J Cell Mol Med2025https://conductscience.org/library/papers/40366255PubMed
36902125Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis.Int J Mol Sci2023https://conductscience.org/library/papers/36902125PubMed
35155241Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells.Front Oncol2022https://conductscience.org/library/papers/35155241PubMed
32648934In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer.Biotechnol Bioeng2020https://conductscience.org/library/papers/32648934PubMed
29671772Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms.Cancers (Basel)2018https://conductscience.org/library/papers/29671772PubMed
28965853Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.Cancer Lett2017https://conductscience.org/library/papers/28965853PubMed
28758107Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer.Medicines (Basel)2017https://conductscience.org/library/papers/28758107PubMed
28460441Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.Oncotarget2017https://conductscience.org/library/papers/28460441PubMed
28009978The secretion and biological function of tumor suppressor maspin as an exosome cargo protein.Oncotarget2017https://conductscience.org/library/papers/28009978PubMed
26958085Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression.J Cancer2016https://conductscience.org/library/papers/26958085PubMed
26404901Microfluidic cytometric analysis of cancer cell transportability and invasiveness.Sci Rep2015https://conductscience.org/library/papers/26404901PubMed
25701047COX-2 dependent regulation of mechanotransduction in human breast cancer cells.Cancer Biol Ther2015https://conductscience.org/library/papers/25701047PubMed
25184143E-cadherin and gastric cancer: cause, consequence, and applications.Biomed Res Int2014https://conductscience.org/library/papers/25184143PubMed
24291763Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.Int J Biochem Cell Biol2014https://conductscience.org/library/papers/24291763PubMed
23689139Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization.Cancer Lett2013https://conductscience.org/library/papers/23689139PubMed
23386909In Vitro Assessment of the Inflammatory Breast Cancer Cell Line SUM 149: Discovery of 2 Single Nucleotide Polymorphisms in the RNase L Gene.J Cancer2013https://conductscience.org/library/papers/23386909PubMed
23320987TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.J Hematol Oncol2013https://conductscience.org/library/papers/23320987PubMed
22937154Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.PLoS One2012https://conductscience.org/library/papers/22937154PubMed
22440943E-cadherin's dark side: possible role in tumor progression.Biochim Biophys Acta2012https://conductscience.org/library/papers/22440943PubMed

See all 27 cited byDownload CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15857504

GET https://conductscience.org/api/papers/v1/15857504/references?page=2